Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain

OBJECTIVE: Successful clinical trials are subject to recruitment. Recently, the REJUVENATE trial, a prospective phase 2a open-label, single-arm interventional clinical trial conducted within the Innovative Medicines Initiative-supported Combatting Bacterial Resistance in Europe-Carbapenem Resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Jimenez-Rodriguez, Rosa M, Martín-Gutiérrez, Guillermo, Jiménez-Jorge, Silvia, Rosso-Fernández, Clara M, Tallón-Aguilar, Luis, Roca-Oporto, Cristina, Padillo, Javier, Luckey, Alison, Cano, Angela, López-Ruiz, José, Gómez-Zorrilla, Silvia, Bonnín-Pascual, Jaime, Boix-Palop, Lucía, Montejo, José Miguel, Torre-Cisneros, Julian, Cisneros, José Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814749/
https://www.ncbi.nlm.nih.gov/pubmed/35115349
http://dx.doi.org/10.1136/bmjopen-2021-051187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814749/
https://www.ncbi.nlm.nih.gov/pubmed/35115349
http://dx.doi.org/10.1136/bmjopen-2021-051187

Ejemplares similares